Identification of a novel role of T cells in postnatal vasculogenesis - Characterization of endothelial progenitor cell colonies
Identification of a novel role of T cells in postnatal vasculogenesis - Characterization of endothelial progenitor cell colonies
复制标题
DOI:
10.1161/circulationaha.107.694778
复制
发表时间:
2007-10-09
期刊:
影响因子:
37.8
通讯作者:
Kim, Hyo-Soo
中科院分区:
文献类型:
--
作者:
Hur, Jin;Yang, Han-Mo;Kim, Hyo-Soo
Background - The colony number of early endothelial progenitor cells ( EPCs) has been used as a quantitative indicator of the number of EPCs in the blood or as a biological marker of cardiovascular diseases. In the present study, we found a subset of T cells that were localized at the center of the EPC colony and played a pivotal role in colony formation and differentiation of early EPCs.Methods and Results - We found that CD3(+)CD31(+)CXCR4(+) T cells ( referred to as angiogenic T cells in the present study) constituted the center of EPC colonies during cultures of human peripheral blood mononuclear cells. These angiogenic T cells were required for colony formation and differentiation of early EPCs. They secreted high levels of angiogenic cytokines such as vascular endothelial growth factor, interleukin- 8, and matrix metalloproteinases. Angiogenic T cells showed superior angiogenic potential to the other subset of T cells in the experiments with regard to Matrigel tube formation, adhesion, transendothelial migration, and collagen invasion assay, mainly through the stromal cell - derived factor 1/CXCR- 4 axis. Furthermore, angiogenic T cells enhanced endothelial cell proliferation and function. In vivo study showed that angiogenic T cells play an important role in the process of vessel formation. Clinical study showed that the level of angiogenic T cells in the peripheral blood was well correlated with EPC colony numbers and had inverse relationships with age and the number of risk factors for coronary artery disease.Conclusions - These findings suggest that angiogenic T cells could be a potential therapeutic target for ischemic cardiovascular diseases.